tricalcium phosphate has been researched along with Bone Loss, Perimenopausal in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 7 (46.67) | 29.6817 |
| 2010's | 6 (40.00) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, DC; Cheng, Q; Hao, YQ; He, L; Hu, ZH; Liao, EY; Lin, H; Peng, YD; Song, CL; Tang, H; Wang, J; Wang, L; Wei, F; Xia, WB; You, L; Zhang, L; Zhang, ZL | 1 |
| Ito, T; Makino, K; Otsuka, M; Takemasa, M | 1 |
| Aati, O; Bristow, SM; Gamble, GD; Horne, AM; Horne, L; House, ME; Mihov, B; Reid, IR; Stewart, A | 1 |
| Hsu, LH; Lin, FH; Lu, DH; Wang, CC; Wu, CC; Yang, KC | 1 |
| Angermann, P; Gabl, M; Gschwentner, M; Lutz, M; Pechlaner, S; Zimmermann, R | 1 |
| Kin, Y | 1 |
| Anders, M; Düber, C; Eysel, P; Fürderer, S; Glück, M; Salick, M; Schwindling, B; Urban, R; Wenda, K | 1 |
| Heaney, RP; Lappe, JM; Recker, RR; Watson, P | 1 |
| Abe, M; Kin, A; Tomita, S; Yazu, M | 1 |
| Arlot, M; Chapuy, MC; Lilliu, H; Meunier, PJ; Pamphile, R; Schulten, J | 1 |
| Albertazzi, P; Howarth, EM; Purdie, DW; Steel, SA | 1 |
| Tao, ZS; Xu, HG; Yang, M; Zhou, WS | 1 |
| Bai, B; Boodhun, V; Chen, L; Shen, Z; Tang, J; Wang, B; Weng, S; Wu, Z; Xie, Z; Yan, D; Yang, L; Zhou, Q | 1 |
| Griffith, CS; Pak, CY; Poindexter, JR; Sakhaee, K | 1 |
5 trial(s) available for tricalcium phosphate and Bone Loss, Perimenopausal
| Article | Year |
|---|---|
Calcifediol (25-hydroxyvitamin D) improvement and calcium-phosphate metabolism of alendronate sodium/vitamin D
Topics: Aged; Aged, 80 and over; Alendronate; Biomarkers; Bone Density; Bone Density Conservation Agents; Calcifediol; Calcium Phosphates; China; Cholecalciferol; Female; Humans; Hypercalciuria; Middle Aged; Osteoporosis, Postmenopausal; Treatment Outcome; Vitamin D; Vitamin D Deficiency | 2018 |
Acute and 3-month effects of microcrystalline hydroxyapatite, calcium citrate and calcium carbonate on serum calcium and markers of bone turnover: a randomised controlled trial in postmenopausal women.
Topics: Aged; Biomarkers; Bone Density Conservation Agents; Bone Remodeling; Bone Resorption; Calcium; Calcium Carbonate; Calcium Citrate; Calcium Phosphates; Calcium, Dietary; Collagen Type I; Dietary Supplements; Durapatite; Female; Humans; Osteoporosis, Postmenopausal; Peptides; Phosphates; Postmenopause | 2014 |
Phosphate and carbonate salts of calcium support robust bone building in osteoporosis.
Topics: Administration, Oral; Aged; Body Mass Index; Bone Density; Bone Development; Calcium; Calcium Carbonate; Calcium Phosphates; Cholecalciferol; Female; Humans; Injections, Subcutaneous; Middle Aged; Osteoporosis, Postmenopausal; Patient Selection; Single-Blind Method; Tablets | 2010 |
Comparison of the effects of two different types of calcium supplementation on markers of bone metabolism in a postmenopausal osteopenic population with low calcium intake: a double-blind placebo-controlled trial.
Topics: Aged; Alkaline Phosphatase; Biomarkers; Bone Density; Bone Remodeling; Calcium Phosphates; Collagen Type I; Double-Blind Method; Durapatite; Female; Humans; Osteocalcin; Osteoporosis, Postmenopausal; Peptide Fragments; Prospective Studies; Reference Values | 2004 |
Stone forming risk of calcium citrate supplementation in healthy postmenopausal women.
Topics: Aged; Calcium; Calcium Citrate; Calcium Phosphates; Citric Acid; Dietary Supplements; Drug Therapy, Combination; Female; Humans; Hydrogen-Ion Concentration; Middle Aged; Osteoporosis, Postmenopausal; Oxalates; Phosphorus; Postmenopause; Potassium Citrate; Risk Factors; Uric Acid; Urinary Calculi | 2004 |
10 other study(ies) available for tricalcium phosphate and Bone Loss, Perimenopausal
| Article | Year |
|---|---|
Preparation of calcium phosphate nanocapsules including simvastatin/deoxycholic acid assembly, and their therapeutic effect in osteoporosis model mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bone and Bones; Bone Density Conservation Agents; Calcium Phosphates; Cell Line; Deoxycholic Acid; Disease Models, Animal; Drug Compounding; Drug Delivery Systems; Female; Humans; Hypolipidemic Agents; Mice; Mice, Inbred Strains; Micelles; Nanocapsules; Osteoporosis, Postmenopausal; Random Allocation; Simvastatin; Surface Properties; Surface-Active Agents | 2013 |
Calcium phosphate cement delivering zoledronate decreases bone turnover rate and restores bone architecture in ovariectomized rats.
Topics: Animals; Bone Cements; Bone Density Conservation Agents; Bone Resorption; Calcium Phosphates; Diphosphonates; Female; Humans; Imidazoles; Osteoporosis, Postmenopausal; Ovariectomy; Rats; Rats, Wistar; Treatment Outcome; Zoledronic Acid | 2012 |
Injectable calcium phosphate bone cement Norian SRS for the treatment of intra-articular compression fractures of the distal radius in osteoporotic women.
Topics: Aged; Bone Cements; Calcium Phosphates; Female; Fracture Fixation, Internal; Fracture Healing; Hand Strength; Humans; Injections, Intralesional; Injury Severity Score; Middle Aged; Osteoporosis, Postmenopausal; Probability; Prospective Studies; Radius Fractures; Range of Motion, Articular; Recovery of Function; Risk Assessment; Tomography, X-Ray Computed; Treatment Outcome; Wrist Injuries | 2003 |
[Histological observations of hydroxyapatite thermal decomposition product injected into the femur of ovariectomized rats].
Topics: Animals; Biocompatible Materials; Bone Cements; Bone Development; Calcium Phosphates; Disease Models, Animal; Durapatite; Female; Femur; Hot Temperature; Humans; Osteoporosis, Postmenopausal; Ovariectomy; Rats; Rats, Wistar | 1994 |
[Vertebral body stenting. A method for repositioning and augmenting vertebral compression fractures].
Topics: Aged; Bone Substitutes; Calcium Phosphates; Catheterization; Equipment Design; Female; Fracture Fixation, Internal; Fractures, Spontaneous; Humans; Lumbar Vertebrae; Osteoporosis, Postmenopausal; Spinal Fractures; Stents; Tomography, X-Ray Computed | 2002 |
Biomechanical evaluation of kyphoplasty and vertebroplasty with calcium phosphate cement in a simulated osteoporotic compression fracture.
Topics: Aged; Aged, 80 and over; Biocompatible Materials; Biomechanical Phenomena; Bone Cements; Calcium Phosphates; Female; Humans; Osteoporosis, Postmenopausal; Spinal Fractures | 2003 |
Calcium-vitamin D3 supplementation is cost-effective in hip fractures prevention.
Topics: Aged; Calcium Phosphates; Cholecalciferol; Cost-Benefit Analysis; Drug Costs; Drug Therapy, Combination; Europe; Female; Health Care Costs; Hip Fractures; Humans; Osteoporosis, Postmenopausal | 2003 |
Aspirin modified strontium-doped β-tricalcium phosphate can accelerate the healing of femoral metaphyseal defects in ovariectomized rats.
Topics: 3T3 Cells; Animals; Anti-Inflammatory Agents; Aspirin; Bone Density; Bone Morphogenetic Protein 2; Bone Remodeling; Bone Substitutes; Calcium Phosphates; Disease Models, Animal; Female; Femur; Humans; Mice; Osteoblasts; Osteogenesis; Osteoporosis, Postmenopausal; Osteoprotegerin; Ovariectomy; RANK Ligand; Rats, Sprague-Dawley; Signal Transduction; Smad1 Protein; Strontium; Wound Healing | 2020 |
The fast degradation of β-TCP ceramics facilitates healing of bone defects by the combination of BMP-2 and Teriparatide.
Topics: Animals; Biocompatible Materials; Bone Morphogenetic Protein 2; Calcium Phosphates; Drug Therapy, Combination; Female; Humans; Osteogenesis; Osteoporosis, Postmenopausal; Ovariectomy; Random Allocation; Rats; Teriparatide | 2019 |
[Osteoporosis in women. Fewer falls with minerals plus vitamin D].
Topics: Accidental Falls; Aged; Bone Density; Calcium Gluconate; Calcium Phosphates; Cholecalciferol; Drug Combinations; Female; Humans; Osteoporosis, Postmenopausal | 2000 |